Integral Molecular: Funding, Investors & Team (Oct 2026)
Integral Molecular's goal is to develop and employ innovative technologies to facilitate the discovery of therapies for difficult protein targets. With their extensive expertise in membrane proteins and antibodies, the company has aided over 400 organizations in various fields such as research, drug development, and vaccine creation.
Integral Molecular has raised $9.9M across 3 funding rounds on record, the most recent an undisclosed round of $8.0M announced in Oct 2024.
That round is in line with the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Integral Molecular Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Integral Molecular Funding Rounds
Integral Molecular raised $1.0M in an undisclosed round announced in Jun 2023.
4 months later, an undisclosed round of $900k was announced in Oct 2023.
1 years later, an undisclosed round of $8.0M was announced in Oct 2024.
Integral Molecular Founders and Leadership Team
Contact details for the Integral Molecular team: 1 of 1 has an email address on file.
Start 14-day free trial →Integral Molecular Funding Compared to Other Biotechnology Startups
Integral Molecular's latest round of $8.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Integral Molecular in Biotechnology and Philadelphia
Companies Similar to Integral Molecular
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Integral Molecular Funding FAQs
What does Integral Molecular do?
Integral Molecular's goal is to develop and employ innovative technologies to facilitate the discovery of therapies for difficult protein targets. With their extensive expertise in membrane proteins and antibodies, the company has aided over 400 organizations in various fields such as research, drug development, and vaccine creation.
How much funding has Integral Molecular raised?
Integral Molecular has raised $9.9M across 3 rounds on record. The most recent is an undisclosed round of $8.0M announced in Oct 2024.
When did Integral Molecular last raise funding?
Integral Molecular's most recent funding round on record is an undisclosed round of $8.0M, announced in Oct 2024.
Who founded Integral Molecular?
FundedIQ lists Joseph Rucker (Founder) at Integral Molecular.
Where is Integral Molecular headquartered?
Integral Molecular is based in Philadelphia, Pennsylvania, United States.
How many employees does Integral Molecular have?
Integral Molecular is in the 51-100 employee band.
How does Integral Molecular's funding compare to other Biotechnology startups?
Integral Molecular's latest round of $8.0M is in line with the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Integral Molecular Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Integral Molecular is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.